FDA Issues Guidance on Generic Abuse-Deterrent Opioid Development
November 22nd 2017Officials with the FDA have released a guidance on the development of generic abuse-deterrent opioids. The final guidance is part of the agency’s effort to reduce abuse by decreasing unnecessary exposure to opioids.
Read More